Chronic inflammatory diseases
Conditions
Interventions
None listed
Sponsors
Fresenius Kabi SwissBioSim GmbH
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Countries
Poland
Outcome results
None listed